Peijia Medical Limited Market Cap ($299.00 Million)
Market Cap & Net Worth: Peijia Medical Limited (4WO)
Peijia Medical Limited market cap. Peijia Medical Limited (F:4WO) has a market capitalization of $299.00 Million (€255.75 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #14441 globally and #1457 in its home market, demonstrating a -15.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Peijia Medical Limited's stock price €0.38 by its total outstanding shares 669511953 (669.51 Million). Also see cash efficiency ratio of Peijia Medical Limited for how efficiently the company converts equity into cash flow.
Peijia Medical Limited Market Cap History (2020–2026)
Peijia Medical Limited market cap history from 2020 to 2026. Data shows change from $2.24 Billion to $299.00 Million (-27.35% CAGR). Check 4WO share price today for real-time trading data and today's change.
Peijia Medical Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Peijia Medical Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 4WO net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.71x
Peijia Medical Limited's market cap is 0.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.24 Billion | $38.66 Million | -$2.07 Billion | 57.91x | N/A |
| 2021 | $1.06 Billion | $136.53 Million | -$574.22 Million | 7.80x | N/A |
| 2022 | $861.00 Million | $250.83 Million | -$407.81 Million | 3.43x | N/A |
| 2023 | $700.54 Million | $441.13 Million | -$392.52 Million | 1.59x | N/A |
| 2024 | $372.58 Million | $615.48 Million | -$226.58 Million | 0.61x | N/A |
| 2025 | $508.77 Million | $712.87 Million | -$203.29 Million | 0.71x | N/A |
Competitor Companies of 4WO by Market Capitalization
Companies near Peijia Medical Limited in the global market cap rankings as of November 4, 2026. Also see total assets of Peijia Medical Limited for a full breakdown of the balance sheet.
Key companies related to Peijia Medical Limited by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Peijia Medical Limited (2020–2026)
Market capitalization of Peijia Medical Limited from 2020 to today. Between 2020 and today, Peijia Medical Limited's market cap moved from $2.24 Billion to $ 299.00 Million, with a yearly change of -27.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €299.00 Million | -41.23% |
| 2025 | €508.77 Million | +36.55% |
| 2024 | €372.58 Million | -46.82% |
| 2023 | €700.54 Million | -18.64% |
| 2022 | €861.00 Million | -19.12% |
| 2021 | €1.06 Billion | -52.45% |
| 2020 | €2.24 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Peijia Medical Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $299.00 Million USD |
| MoneyControl | $299.00 Million USD |
| MarketWatch | $299.00 Million USD |
| marketcap.company | $299.00 Million USD |
| Reuters | $299.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Peijia Medical Limited
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more